dbGaP

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.

This subject phenotype table contains de-identified subject ID, study center and phase, reference age, year of birth, jewish ethnicity, race or ethnicity, body mass index, weight at reference age, height, menopausal status, smoking status, ever diagnosed with asthma, age when asthma was diagnosed, family history of ovarian cancer or premenopausal breast cancer, personal history of breast cancer, ever regularly used acetaminophen, aspirin or ibuprofen, ever used postmenopausal hormone therapy among postmenopausal subjects, ovulatory cycles, endometriosis or painful periods, parity, duration of breastfeeding, hysterectomy, age at hysterectomy, tubal ligation, age at tubal ligation, histologic type, alcohol consumption, birth control (n=4 variables; condoms, diaphragm or IUD ever used regularly or as primary method of birth control, and oral contraceptive use), husband or regular partner used body powder on his genital or rectal area, and powder applied to genital or rectal areas, non-genital or non-rectal areas, sanitary napkins or tampons, and underwear. The powder use counts times used per month, months used per year, age at first use, years used, first and second brand codes, texts, and contents.